Medicxi launches first $300m late-stage life sciences fund Medicxi Growth 1 (MG1), backed by Novartis and Verily

25.06.2017 | Medicxi announced on June 15th the close of Medicxi Growth 1 (MG1), a new $300 million fund that will focus on growth ...

CeGaT Obtains CLIA Certification, Final Step Towards U.S. Market Entry

21.06.2017 | CeGaT GmbH, a leading global genetic testing provider focused on large panel and trio-exome diagnostics, has obtained its CLIA certification. ...

Safe medications thanks to new test procedures

24.05.2017 | High-Tech Gründerfonds is investing EUR 600,000 in Reutlingen-based SIGNATOPE GmbH. SIGNATOPE will use the funds to advance the development of its unique biomarker assay system, that ...

Summer Reception of BioRegio STERN Management GmbH

The summer reception of BioRegio STERN Management GmbH is an annual meeting place for entrepreneurs, researchers and founders in the BioRegion STERN as well as beyond. We would ...